We are live on ! Find out more
SAM

Sectoral Asset Management Portfolio holdings

AUM $121M
1-Year Est. Return 73.47%
This Fund
S&P 500
This Quarter Est. Return
+11.43%
1 Year Est. Return
+73.47%
3 Year Est. Return
+165.77%
5 Year Est. Return
+169.27%
10 Year Est. Return
+1,136.49%
AUM
$2.35B
AUM Growth
+$162M
Cap. Flow
+$9.89M
Cap. Flow %
0.42%
Top 10 Hldgs %
51.28%
Holding
86
New
9
Increased
45
Reduced
20
Closed
11

Top Buys

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$49.7M
2
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$40.7M
3
INCY icon
Incyte
INCY
+$26.8M
4
PTCT icon
PTC Therapeutics
PTCT
+$26.4M
5
NBIX icon
Neurocrine Biosciences
NBIX
+$21.2M

Top Sells

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$96M
2
PFE icon
Pfizer
PFE
+$53.7M
3
PTLA
Portola Pharmaceuticals, Inc.
PTLA
+$46.4M
4
AGN
Allergan plc
AGN
+$36.3M
5
RLYP
RELYPSA INC COM
RLYP
+$15.6M

Sector Composition

Rank Sector Weight
1 Healthcare 97.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AGN
51
DELISTED
Allergan plc
AGN
$6.31M 0.27%
20,192
-121,817
-86% -$36.3M
RGNX icon
52
Regenxbio
RGNX
$615M
$5.82M 0.25%
350,700
-156,741
-31% -$3.11M
RDY icon
53
Dr. Reddy's Laboratories
RDY
$9.77B
$5.63M 0.24%
607,930
-666,575
-52% -$7.3M
CMRX
54
DELISTED
Chimerix, Inc.
CMRX
$4.92M 0.21%
550,100
+73,600
+15% +$2.65M
PRGO icon
55
Perrigo
PRGO
$1.43B
$4.32M 0.18%
29,821
+2,960
+11% +$455K
MNK
56
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
$3.97M 0.17%
53,154
+14,902
+39% +$1M
MNTA
57
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
$2.85M 0.12%
191,737
+41,394
+28% +$693K
AKRX
58
DELISTED
Akorn Inc
AKRX
$2.4M 0.1%
64,403
-4,110
-6% -$129K
NKTR icon
59
Nektar Therapeutics
NKTR
$2.39B
$2.31M 0.1%
9,142
+2,182
+31% +$449K
ALKS icon
60
Alkermes
ALKS
$8.42B
$2.06M 0.09%
25,895
-4,116
-14% -$288K
MCK icon
61
McKesson
MCK
$104B
$2.05M 0.09%
10,401
+1,177
+13% +$222K
IPXL
62
DELISTED
Impax Laboratories, Inc.
IPXL
$2.01M 0.09%
47,031
-5,280
-10% -$211K
EGRX
63
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$1.94M 0.08%
21,899
-6,253
-22% -$494K
JAZZ icon
64
Jazz Pharmaceuticals
JAZZ
$16.1B
$1.91M 0.08%
13,550
+1,144
+9% +$159K
ENDP
65
DELISTED
Endo International plc
ENDP
$1.9M 0.08%
31,062
+6,426
+26% +$390K
ASRT
66
DELISTED
Assertio
ASRT
$1.69M 0.07%
1,553
+353
+29% +$397K
CTLT
67
DELISTED
CATALENT, INC.
CTLT
$1.53M 0.07%
61,234
+41,785
+215% +$1.1M
CBM
68
DELISTED
Cambrex Corporation
CBM
$1.19M 0.05%
25,231
+9,863
+64% +$474K
AMPH icon
69
Amphastar Pharmaceuticals
AMPH
$888M
$1.03M 0.04%
72,753
+30,953
+74% +$409K
IRWD icon
70
Ironwood Pharmaceuticals
IRWD
$626M
$948K 0.04%
+97,624
New +$944K
CBPO
71
DELISTED
China Biologic Products Holdings, Inc.
CBPO
$839K 0.04%
5,890
-950
-14% -$110K
ASND icon
72
Ascendis Pharma A/S
ASND
$16.7B
$570K 0.02%
31,100
– –
CHRS icon
73
Coherus Oncology
CHRS
$222M
$366K 0.02%
15,940
-558
-3% -$14.4K
BHC icon
74
Bausch Health
BHC
$1.69B
– –
-17,839
Closed -$3.18M
KPTI icon
75
Karyopharm Therapeutics
KPTI
$161M
– –
-47,531
Closed -$7.51M
1 2
3
4

Similar funds

RIP
Reliant Investment Partners Pinehurst, North Carolina $121M AUM 34.77% 1-Year Est. Return
LFWA
LiftPoint Family Wealth Advisors Far Hills, New Jersey $121M AUM
CF
Conquis Financial Milbrae, California $121M AUM 16.22% 1-Year Est. Return
WIM
Wiregrass Investment Management Thomasville, Georgia $121M AUM
MW
Merited Wealth North Bay Village, Florida $121M AUM
AFC
Avise Financial Cooperative Los Angeles, California $121M AUM
AAA
AG Asset Advisory Los Angeles, California $121M AUM 10.78% 1-Year Est. Return
TGM
Tenzing Global Management San Francisco, California $121M AUM 85.62% 1-Year Est. Return

Sectoral Asset Management's Q4 2015 Portfolio in Review

As of Q4 2015, Sectoral Asset Management held 86 positions worth $2.35B, up 7.4% from $2.18B the previous quarter. Its ten largest holdings account for 51% of the portfolio.

Sectoral Asset Management's Q4 2015 filing shows 9 new, 45 increased, 20 reduced and 11 closed positions. Its largest new stake was Eli Lilly: 599,245 shares worth $50.5M. The largest sale was Biogen, an estimated $96M.

By sector, the portfolio is most concentrated in Healthcare at 97% of assets, up from 94% a quarter earlier.

  • Sectoral Asset Management's largest Q4 2015 buy was Eli Lilly: 599,245 shares worth $50.5M.
  • Sectoral Asset Management added most to BioMarin Pharmaceuticals in Q4 2015, an estimated $40.7M increase.
  • Sectoral Asset Management's biggest Q4 2015 reduction was Biogen, cutting an estimated $96M.
  • Sectoral Asset Management fully exited Pfizer in Q4 2015, selling an estimated $53.7M.
  • Sectoral Asset Management's ten largest holdings make up 51% of its $2.35B portfolio in Q4 2015.
  • Sectoral Asset Management opened 9 new positions and closed 11 in Q4 2015.
  • Sectoral Asset Management's portfolio value rose 7.4% quarter-over-quarter to $2.35B.

Based on Sectoral Asset Management's 13F filing for Q4 2015, filed 12 Feb 2016.